The Recall Desk

Hazard

Sterility recalls

2,383 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
2,383
Critical
1
Severe
2,113
Most recent
2026-08-26

Of the 2,383 sterility recalls we have scored against our rubric, 1 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,113 (89%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all sterility recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

501–525 of 2383

  • SevereFDA (Drugs)·D-1683-2019·2019-08-14

    RXQ Compounding Recalls Midazolam Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Midazolam 1mg/mL injection syringes because the company cannot assure the product's sterility.

    Product
    MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1663-2019·2019-08-14

    RXQ Compounding Recalls Glutathione Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Glutathione 200mg/mL Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0906-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1645-2019·2019-08-14

    RXQ Compounding Recalls Dexpantenol Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dexpantenol 250mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0932-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1702-2019·2019-08-14

    RXQ Compounding Recalls Ropivacaine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ropivacaine 0.2% Injection Solution in On-Q Pumps because the product lacks assurance of sterility.

    Product
    ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0238-55
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1639-2019·2019-08-14

    RXQ Compounding Recalls Buffered Lidocaine HCL 1% Injection Solution

    RXQ Compounding LLC is recalling Buffered Lidocaine HCL 1% Injection Solution due to a lack of assurance of sterility.

    Product
    BUFFERED LIDOCAINE HCL 1% INJECTION SOLUTION (PF), 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0139-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1686-2019·2019-08-14

    RXQ Compounding Recalls Morphine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Morphine 1mg/mL in NaCl 0.9% 55mL syringes because the company cannot ensure the product is sterile.

    Product
    MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1690-2019·2019-08-14

    RXQ Compounding Recalls Ondansetron Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ondansetron 2 mg/mL Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1700-2019·2019-08-14

    RXQ Compounding Recalls Pyridoxine Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Pyridoxine (PFV) 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0955-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1669-2019·2019-08-14

    RXQ Compounding Recalls Ketamine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Ketamine 50 mg/mL injection solution because the product lacks assurance of sterility.

    Product
    KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1668-2019·2019-08-14

    RXQ Compounding Recalls Inositol/Choline B12:B6 Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Inositol/Choline B12:B6 injection solution because there is a lack of assurance of sterility.

    Product
    Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0999-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1659-2019·2019-08-14

    RXQ Compounding Recalls Fentanyl and Bupivacaine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Fentanyl and Bupivacaine syringes nationwide due to a lack of assurance of sterility.

    Product
    FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1665-2019·2019-08-14

    RXQ Compounding Recalls Hydromorphone Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling hydromorphone syringes because the company cannot ensure the product is sterile.

    Product
    HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1664-2019·2019-08-14

    RXQ Compounding Recalls Hydrogen Peroxide Injectable Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydrogen Peroxide 3% Injectable PFV because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0907-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1514-2019·2019-07-31

    Baxter Recalls Sodium Chloride Injection Due to Sterility Concerns

    Baxter Healthcare is recalling 139,680 containers of 0.9% Sodium Chloride Injection due to a lack of assurance of sterility and potential for bags to leak.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1486-2019·2019-07-24

    Pfizer Recalls Milrinone Lactate Injection Bags Due to Sterility Concerns

    Pfizer is recalling 58,200 bags of Milrinone Lactate Injection in 5% Dextrose due to a lack of assurance of sterility and potential for bag leaks.

    Product
    Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection 40 mg/200 mL, 200 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-02, Barcode (01)00304092776028.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1487-2019·2019-07-24

    Pfizer Recalls Milrinone Lactate Injection Bags Due to Sterility Concerns

    Pfizer is recalling specific lots of Milrinone Lactate Injection bags because they may leak, compromising sterility.

    Product
    Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1474-2019·2019-07-17

    FDA Recalls Hydroxyprogesterone Caproate Injection Due to Sterility Concerns

    First Pharma Associates is recalling Hydroxyprogesterone Caproate 250 mg/mL injections due to a lack of assurance of sterility. The recall affects vials distributed in Idaho and Washington.

    Product
    Hydroxyprogesterone Caproate 250 mg/mL Sesame Oil Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1479-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection because the sterility of the product cannot be assured.

    Product
    PAP/PHEN/PGE1 22 mg/0.8mg/8mcg/mL Injection, 5mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1482-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility.

    Product
    PAP/PHEN/PGE1 18 mg/0.6mg/5.88mcg/mL Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1475-2019·2019-07-17

    Riverpoint Pharmacy Recalls Prostaglandin Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling Prostaglandin 20 mcg/mL/Procaine 0.1% Injection due to a lack of assurance of sterility.

    Product
    Prostaglandin 20 mcg/mL/Procaine 0.1% Injection, packaged in a) 2.5mL and b)10 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205 (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1481-2019·2019-07-17

    FDA Recalls Riverpoint Pharmacy Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1472-2019·2019-07-17

    Testosterone Cypionate Injection Recalled for Sterility Assurance Concerns

    First Pharma Associates is recalling Testosterone Cypionate 100 mg/mL oil injections due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Testosterone Cypionate 100 mg/mLOil Injection Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1480-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility.

    Product
    PAP/PHEN/PGE1 30 mg/2mg/20mcg/mL Injection, 10mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1473-2019·2019-07-17

    Riverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific vials of Testosterone Cyp/Estradiol Cyp Injection because of a lack of assurance of sterility.

    Product
    Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL Injection, 3mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1476-2019·2019-07-17

    Hydroxocobalamin Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Hydroxocobalamin 10 mg/mL Injection due to a lack of assurance of sterility. The product is distributed in Idaho and Washington.

    Product
    Hydroxocobalamin 10 mg/mL Injection (ALT) Solution, 30 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states